다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) 뉴스

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALTH

<< 이전 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2010/01/30	06:09	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/01/20	05:53	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/01/13	09:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/01/12	09:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/01/07	08:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/01/06	22:00	Business Wire	Allos Therapeutics to Present at J.P. Morgan Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/01/05	07:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/11	20:25	Marketwired	Wall St Sense Offers In-depth Research on the Services, Financial and Healthcare Sectors' Key Players	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/08	23:31	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/08	23:15	Business Wire	Allos Therapeutics’ FOLOTYN™ Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Ly...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/08	03:22	Dow Jones News	2nd UPDATE: Celgene To Buy Gloucester Pharma for At Least $340 Million	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/08	00:00	Business Wire	Allos Therapeutics’ FOLOTYN™ Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Tre...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/07	22:41	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/06	00:00	Business Wire	Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN™ at 51st ASH Annual Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/04	22:11	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/04	22:00	Business Wire	Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN™ (pralatrexate injection)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/04	05:04	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/03	22:00	Business Wire	Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematolo...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/12/01	06:07	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/30	22:00	Business Wire	Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/23	20:38	Marketwired	Ridgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn En	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/11	22:00	Business Wire	Allos Therapeutics Announces New Data on FOLOTYN™ to be Presented at the American Society of Hematology Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/11	20:54	Marketwired	AnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOP	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/10	23:51	Business Wire	Allos Therapeutics to Present at Upcoming Conferences in November	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/04	06:11	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/04	06:01	Business Wire	Allos Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/11/02	19:12	Marketwired	Global Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.com	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/10/26	21:00	Business Wire	Allos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/10/22	19:57	Marketwired	BenchmarkJournal.com Provides Sector & Company Analysis on OMC, PSE, PWR, ALTH, NWSA and ELNK	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2009/10/14	05:23	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)

검색 관련기사 보기:NASDAQ:ALTH

<< 이전 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 다음 >>

EZTCG116 Ex:11,6

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관